Infection in solid organ transplantation
- 1 March 1999
- journal article
- review article
- Published by Wiley in Transplant Infectious Disease
- Vol. 1 (1) , 21-28
- https://doi.org/10.1034/j.1399-3062.1999.10103.x
Abstract
Infection in the organ transplant recipient is a major determinant of the outcome of transplantation. The attributable mortality from invasive fungal disease and cytomegalovirus disease has been 50 and 30%, respectively. Determinants of infection include epidemiologic exposures to environmental pathogens or exposure to latent infection in the donated organ or recipient, and changes in the net state of immunosuppression. For the past two decades significant improvements have been made in the recognition, prevention and treatment of infections, such as cytomegalovirus and P. carinii. Future research will need to focus on treatment of invasive mold infections, and the management of hepatitis B and C in liver transplantation. In addition, improvement in the prevention of the post-transplant lymphoproliferative disease syndrome will be necessary.Keywords
This publication has 54 references indexed in Scilit:
- Human Herpesvirus‐6 Infection After Liver TransplantationClinical Infectious Diseases, 1998
- The effects of cytomegalovirus serology on graft and recipient survival in cadaveric renal transplantation: Implications for organ allocationAmerican Journal of Kidney Diseases, 1997
- Randomized Trial of Fluconazole versus Nystatin for the Prophylaxis of Candida Infection following Liver TransplantationThe Journal of Infectious Diseases, 1996
- Transmissão da doença de Chagas por transplante renal: ocorrência da forma aguda da doença em dois receptores de um mesmo doadorRevista do Instituto de Medicina Tropical de São Paulo, 1993
- Quantitative Oropharyngeal Epstein-Barr Virus Shedding in Renal and Cardiac Transplant Recipients: Relationship to Immunosuppressive Therapy, Serologic Responses, and the Risk of Posttransplant Lymphoproliferative DisorderThe Journal of Infectious Diseases, 1992
- SYMPTOMATIC CYTOMEGALOVIRUS DISEASE IN THE CYTOMEGALOVIRUS ANTIBODY SEROPOSITIVE RENAL TRANSPLANT RECIPIENT TREATED WITH OKT31,2Transplantation, 1992
- THE INFLUENCE OF DONOR FACTORS OTHER THAN SEROLOGIC STATUS ON TRANSMISSION OF CYTOMEGALOVIRUS TO TRANSPLANT RECIPIENTSTransplantation, 1988
- Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigensNature, 1988
- Glomerulopathy Associated with Cytomegalovirus Viremia in Renal AllograftsNew England Journal of Medicine, 1981
- INFLUENCE OF REJECTION THERAPY ON FUNGAL AND NOCARDIAL INFECTIONS IN RENAL-TRANSPLANT RECIPIENTSThe Lancet, 1973